Login | Register

Pioglitazone Raises Bladder Cancer Risk In Diabetes Patients

Patients with type 2 diabetes who take medication pioglitazone have a higher risk of incident bladder cancer than diabetes patients who do not, researchers from McGill University, Canada, reported in the BMJ. The authors added that bladder cancer risk was also linked to pioglitazone usage duration and dosage...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *